Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Chambers

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Gynecologic Oncology|July 30, 2025
Enhancing predictive accuracy: Assessing the laparoscopic hysterectomy readmission score in a diverse endometrial cancer populationMichelle D S Lightfoot, Jennifer A Sinnott, Caitlin E Meade, et al.
Gynecologic Oncology Reports|April 15, 2021
Survey of trends in authorship assignment in gynecologic oncology: Keeping score and playing fairLaura M Chambers, Catherine H Watson, Meng Yao, et al.
Gynecologic Oncology|July 12, 2021
Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian CancerMorgan Gruner, Laura M Chambers, Meng Yao, et al.
Gynecologic Oncology|January 20, 2021
Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancerAnna Chichura, Laura M Chambers, Anthony B Costales, et al.
Gynecologic Oncology|October 17, 2020
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancerMolly Morton, Laura M Chambers, Anthony B Costales, et al.
Gynecologic Oncology Reports|April 17, 2025
Assessment of readability of informed consent forms of gynecologic cancer clinical trials: A (Potential) barrier to enrollment?Wafa K Khadraoui, Quinn M Kistenfeger, Molly Herman, et al.
Obstetrics and Gynecology|August 3, 2023
Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian CancerMolly Morton, Meng Yao, Julia Chalif, et al.
Gynecologic Oncology|February 8, 2021
Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyLaura M Chambers, Meng Yao, Molly Morton, et al.
Gynecologic Oncology Reports|April 8, 2022
Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancerLaura M Chambers, Meng Yao, Molly Morton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 19, 2021
Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registryLaura M Chambers, Meng Yao, Molly Morton, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|July 30, 2025
Enhancing predictive accuracy: Assessing the laparoscopic hysterectomy readmission score in a diverse endometrial cancer populationMichelle D S Lightfoot, Jennifer A Sinnott, Caitlin E Meade, et al.
Gynecologic Oncology Reports|April 15, 2021
Survey of trends in authorship assignment in gynecologic oncology: Keeping score and playing fairLaura M Chambers, Catherine H Watson, Meng Yao, et al.
Gynecologic Oncology|July 12, 2021
Anastomotic leak following interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in women with advanced epithelial ovarian CancerMorgan Gruner, Laura M Chambers, Meng Yao, et al.
Gynecologic Oncology|January 20, 2021
Impact of intra-operative factors upon peri-operative outcomes in women undergoing hyperthermic intraperitoneal chemotherapy for gynecologic cancerAnna Chichura, Laura M Chambers, Anthony B Costales, et al.
Gynecologic Oncology|October 17, 2020
Assessing feasibility and perioperative outcomes with minimally invasive surgery compared with laparotomy for interval debulking surgery with hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian cancerMolly Morton, Laura M Chambers, Anthony B Costales, et al.
Gynecologic Oncology Reports|April 17, 2025
Assessment of readability of informed consent forms of gynecologic cancer clinical trials: A (Potential) barrier to enrollment?Wafa K Khadraoui, Quinn M Kistenfeger, Molly Herman, et al.
Obstetrics and Gynecology|August 3, 2023
Association of Clinical Trial Participation With Improved Overall Survival for Recurrent, Platinum-Resistant Ovarian CancerMolly Morton, Meng Yao, Julia Chalif, et al.
Gynecologic Oncology|February 8, 2021
Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyLaura M Chambers, Meng Yao, Molly Morton, et al.
Gynecologic Oncology Reports|April 8, 2022
Assessment of travel distance for hyperthermic intraperitoneal chemotherapy in women with ovarian cancerLaura M Chambers, Meng Yao, Molly Morton, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 19, 2021
Perioperative outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in elderly women with epithelial ovarian cancer: analysis of a prospective registryLaura M Chambers, Meng Yao, Molly Morton, et al.
Pageof 8